Skip to main content
. 2020 Oct 9;11:566673. doi: 10.3389/fendo.2020.566673

Table 1.

Characteristics of the women participating in the study stratified by BMI.

Maternal characteristics All Stratified by BMI P
N = 323 Under-/normal weight N = 227 Overweight N = 72 Obese N = 24
Age, years (mean ± SD, N = 322) 29.5 ± 7.0 29.3 ± 7.0 30.4 ± 7.2 28.6 ± 5.9 0.413
Smokers [N (%)] 198 (61.3) 143 (63.0) 39 (54.2) 16 (66.7) 0.348
Gestational age [N (%)] 0.018
    4–6 weeks 134 (41.5) 90 (39.6) 32 (44.4) 12 (50.0)
    7–9 weeks 138 (42.7) 108 (47.6) 21 (29.2) 9 (37.5)
    10–12 weeks 51 (15.8) 29 (12.8) 19 (26.4) 3 (12.5)
BMI, kg/m2 [median (IQR)] 22.7 (20.5–25.4) 21.3 (19.7–22.9) 26.8 (25.7–28.3) 32.3 (31.1–35.3) <0.001
Leptin, ng/ml [median (IQR), N = 321] 9.6 (5.0–15.8) 8.0 (4.0–11.7) 16.2 (9.9–18.6) 20.6 (16.4–29.1) <0.001
Fasting glucose, mmol/l (mean ± SD) 4.7 ± 0.8 4.7 ± 0.8 4.8 ± 0.8 5.0 ± 0.9 0.129
Fasting C-peptide, pmol/l [median (IQR), N = 322] 357.7 (270.1–454.8) 329.1 (258.0–422.1) 414.4 (301.6–404.3) 545.9 (431.7–680.8) <0.001
ISHOMA [median (IQR), N = 322] 0.76 (0.55–1.04) 0.82 (0.61–1.08) 0.68 (0.49–0.89) 0.50 (0.38–0.68) <0.001
IS20/(FCPxFPG) [median (IQR), N = 322] 12.10 (8.85–16.62) 13.12 (9.79–17.35) 10.94 (7.92–14.31) 8.02 (6.04–10.81) <0.001
ISQUICKI (mean ± SD, N = 322) 0.22 ± 0.01 0.23 ± 0.01 0.22 ± 0.01 0.21 ± 0.21 <0.001

BMI, Body mass index (BMI < 25.0 kg/m2: under-/normal weight; BMI 25.0–29.9 kg/m2: overweight; BMI ≥ 30.0 kg/m2: obese); Gestational age, postmenstrual period; ISHOMA, Homeostatic model assessment of insulin sensitivity; IQR, Interquartile range; SD, Standard deviation. Skewed variables were log-transformed before analysis. Statistically significant results in bold.